Indrapr.Medical

{
  "main_header": {
    "sid": 131877,
    "name": "Indrapr.Medical",
    "stock_name": "Indrapr.Medical",
    "full_name": "Indraprastha Medical Corporation Ltd",
    "name_url": "stocks-analysis/indraprmedical",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "375.80",
    "chg": -7.55,
    "chgp": "-1.97%",
    "dir": -1,
    "prev_price": "383.35",
    "mcapval": "3,446.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532150,
    "symbol": "INDRAMEDCO",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE681B01017",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "1.99 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indraprmedical-131877-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indraprastha Medical Gains 3.81%: Downgrade and Volatility Mark the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-gains-381-downgrade-and-volatility-mark-the-week-3827533",
        "imagepath": "",
        "date": "2026-02-08 16:02:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Downgrade to Sell rating announced amid quality and financial concerns</p>\n                    <p><strong>3 Feb:</strong> Stock opens with strong 5.79% gap up, reflecting positive market sentiment</p>\n                    <p><strong>3 Feb:</strong> Q2 FY26 results reveal margin pressure denting profit growth despite revenue gains</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.377.20, up 3.81% for the week, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.363.35</div></div>\n                    <div ..."
      },
      {
        "title": "Are Indraprastha Medical Corporation Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indraprastha-medical-corporation-ltd-latest-results-good-or-bad-3821001",
        "imagepath": "",
        "date": "2026-02-04 19:18:23",
        "description": "Indraprastha Medical Corporation Ltd's latest financial results reveal a complex operational landscape. In Q2 FY26, the company reported a net profit of ₹49.46 crores, reflecting a sequential decline of 3.89%, marking a break from the previous two quarters of profit growth. This decline is attributed to rising employee costs, which surged by 13.29% quarter-on-quarter, consuming a significant portion of the revenue gains. Despite this, the company achieved a revenue growth of 4.37% from the previous quarter, with net sales reaching ₹381.03 crores, indicating sustained demand for healthcare services.\n\nOn a year-on-year basis, the financial performance appears more favorable, with net sales growing by 8.92% compared to ₹349.82 crores in Q2 FY25, and net profit showing a notable increase of 16.65% from ₹42.40 crores. This suggests that the company is successfully expanding its patient base and service offerings..."
      },
      {
        "title": "Indraprastha Medical Q2 FY26: Margin Pressure Dents Profit Growth Despite Revenue Gains",
        "link": "https://www.marketsmojo.com/news/result-analysis/indraprastha-medical-q2-fy26-margin-pressure-dents-profit-growth-despite-revenue-gains-3819052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndraprasthaMed_quaterlyResult_3819052.png",
        "date": "2026-02-03 21:15:37",
        "description": "Indraprastha Medical Corporation Ltd., operator of the flagship Indraprastha Apollo Hospitals in New Delhi, reported a mixed second quarter for FY2026, with net profit declining 3.89% quarter-on-quarter to ₹49.46 crores despite revenue growth of 4.37%. The hospital chain's market capitalisation stands at ₹3,547 crores, though the stock has tumbled 39.44% from its 52-week high of ₹640.05, currently trading at ₹387.60 after a 3.33% gain on February 3, 2026."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3818402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndraprasthaMed_gapup_3818402.png",
        "date": "2026-02-03 11:05:46",
        "description": "Indraprastha Medical Corporation Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a notable gap up of 5.79%, reflecting positive market sentiment despite a recent downgrade in its Mojo Grade. The stock outperformed its sector and the broader market, continuing its upward momentum over the past four days."
      },
      {
        "title": "Indraprastha Medical Corporation Downgraded to Sell Amid Quality and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-downgraded-to-sell-amid-quality-and-financial-concerns-3815691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndraprasthaMed_mojoScore_3815691.png",
        "date": "2026-02-02 08:13:15",
        "description": "Indraprastha Medical Corporation Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a notable shift in its quality assessment and valuation metrics. The downgrade, effective from 30 January 2026, is driven by a combination of deteriorating quality grades, a moderation in valuation attractiveness, flat recent financial trends, and mixed technical signals. This comprehensive analysis explores the four key parameters that influenced the rating change and what it means for investors."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Quality Grade Downgrade: A Detailed Fundamental Analysis",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-quality-grade-downgrade-a-detailed-fundamental-analysis-3813462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndraprasthaMed_qualitydot_3813462.png",
        "date": "2026-02-01 08:00:11",
        "description": "Indraprastha Medical Corporation Ltd has recently seen its quality grade downgraded from excellent to average, reflecting a shift in its business fundamentals. This article analyses the key financial metrics, including return on equity (ROE), return on capital employed (ROCE), debt levels, and growth consistency, to understand the factors behind this change and its implications for investors."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-faces-bearish-momentum-amid-technical-downgrade-3804850",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndraprasthaMed_technicaldot_3804850.png",
        "date": "2026-01-27 08:00:16",
        "description": "Indraprastha Medical Corporation Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish territory. This change accompanies a downgrade in its Mojo Grade from Buy to Hold as of 1 January 2026, reflecting growing caution among investors amid a sharp price correction and weakening trend signals."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-hold-3803137",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndraprasthaMed_mojoScore_3803137.png",
        "date": "2026-01-24 10:10:03",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Forms Death Cross, Signalling Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-forms-death-cross-signalling-bearish-trend-3802353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndraprasthaMed_dealthcross_3802353.png",
        "date": "2026-01-23 18:00:25",
        "description": "Indraprastha Medical Corporation Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness in the hospital sector stock."
      }
    ],
    "total": 392,
    "sid": "131877",
    "stock_news_url": "https://www.marketsmojo.com/news/indraprastha-medical-corporation-131877"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Feb-2026",
      "details": "We hereby submits the copy of public notice of financial results published on 4th February 2026 in Financial Express all India editions in English language and in Jansatta Delhi edition in Hindi language.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "03-Feb-2026",
      "details": "It is hereby informed the board of directors in its meeting held on 03.02.2026 considered and approved the appionment/ re-appiontment of the following : 1. Mr. Harsh Pati Singhania as Additional Director in the catergory of Non Executive Independent Director for a term of 5 years 2. Mr. Salil singhal as Independent director for a second term of 5 years. 3. Ms Vineeta Rai as Independent director for a second term of 5 years. 4. Ms Madhumita Ganguli as Independent director for a second term of 5 years",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "03-Feb-2026",
      "details": "Pursuant to Regulation 30 and 33 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Tuesday the 3rd February 2026 i.e. today considered and approved the following :- 1. Considered and approved unaudited financial results of the Company for the quarter and nine months ended on 31st December 2025. 2. Noted additional affidavit filed by Govt. of NCT of Delhi in the pending Free Patient Matter i.e. SLP (C) No. 29482/2009. 3. Appointed Mr. Harsh Pati Singhania as an additional Director in the category of Non-executive Independent Director for a period of five years. 4. Reappointed Mr. Salil Singhal as an Independent Director for second consecutive term of five years. 5. Reappointed Ms. Vineeta Rai as an Independent Director for second consecutive term of five years. 6. Reappointed Ms. Madhumita Ganguli as Independent Director for second consecutive term of five years.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indraprastha Medical Corporation Ltd has declared <strong>45%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indraprastha Medical Gains 3.81%: Downgrade and Volatility Mark the Week

2026-02-08 16:02:10

Key Events This Week

2 Feb: Downgrade to Sell rating announced amid quality and financial concerns

3 Feb: Stock opens with strong 5.79% gap up, reflecting positive market sentiment

3 Feb: Q2 FY26 results reveal margin pressure denting profit growth despite revenue gains

6 Feb: Week closes at Rs.377.20, up 3.81% for the week, outperforming Sensex

Week Open

Rs.363.35

Read full news article

Are Indraprastha Medical Corporation Ltd latest results good or bad?

2026-02-04 19:18:23

Indraprastha Medical Corporation Ltd's latest financial results reveal a complex operational landscape. In Q2 FY26, the company reported a net profit of ₹49.46 crores, reflecting a sequential decline of 3.89%, marking a break from the previous two quarters of profit growth. This decline is attributed to rising employee costs, which surged by 13.29% quarter-on-quarter, consuming a significant portion of the revenue gains. Despite this, the company achieved a revenue growth of 4.37% from the previous quarter, with net sales reaching ₹381.03 crores, indicating sustained demand for healthcare services. On a year-on-year basis, the financial performance appears more favorable, with net sales growing by 8.92% compared to ₹349.82 crores in Q2 FY25, and net profit showing a notable increase of 16.65% from ₹42.40 crores. This suggests that the company is successfully expanding its patient base and service offerings...

Read full news article

Indraprastha Medical Q2 FY26: Margin Pressure Dents Profit Growth Despite Revenue Gains

2026-02-03 21:15:37

Indraprastha Medical Corporation Ltd., operator of the flagship Indraprastha Apollo Hospitals in New Delhi, reported a mixed second quarter for FY2026, with net profit declining 3.89% quarter-on-quarter to ₹49.46 crores despite revenue growth of 4.37%. The hospital chain's market capitalisation stands at ₹3,547 crores, though the stock has tumbled 39.44% from its 52-week high of ₹640.05, currently trading at ₹387.60 after a 3.33% gain on February 3, 2026.

Read full news article

Indraprastha Medical Corporation Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 11:05:46

Indraprastha Medical Corporation Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a notable gap up of 5.79%, reflecting positive market sentiment despite a recent downgrade in its Mojo Grade. The stock outperformed its sector and the broader market, continuing its upward momentum over the past four days.

Read full news article

Indraprastha Medical Corporation Downgraded to Sell Amid Quality and Financial Concerns

2026-02-02 08:13:15

Indraprastha Medical Corporation Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a notable shift in its quality assessment and valuation metrics. The downgrade, effective from 30 January 2026, is driven by a combination of deteriorating quality grades, a moderation in valuation attractiveness, flat recent financial trends, and mixed technical signals. This comprehensive analysis explores the four key parameters that influenced the rating change and what it means for investors.

Read full news article

Indraprastha Medical Corporation Ltd Quality Grade Downgrade: A Detailed Fundamental Analysis

2026-02-01 08:00:11

Indraprastha Medical Corporation Ltd has recently seen its quality grade downgraded from excellent to average, reflecting a shift in its business fundamentals. This article analyses the key financial metrics, including return on equity (ROE), return on capital employed (ROCE), debt levels, and growth consistency, to understand the factors behind this change and its implications for investors.

Read full news article

Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-01-27 08:00:16

Indraprastha Medical Corporation Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish territory. This change accompanies a downgrade in its Mojo Grade from Buy to Hold as of 1 January 2026, reflecting growing caution among investors amid a sharp price correction and weakening trend signals.

Read full news article

Indraprastha Medical Corporation Ltd is Rated Hold

2026-01-24 10:10:03

Indraprastha Medical Corporation Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Indraprastha Medical Corporation Ltd Forms Death Cross, Signalling Bearish Trend

2026-01-23 18:00:25

Indraprastha Medical Corporation Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness in the hospital sector stock.

Read full news article

View All News